AzTrials
AzTrials

Atrophied Posterior Maxillary RidgeNCT02577289

Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite

A study testing Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite) and Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF) in people with Atrophied Posterior Maxillary Ridge, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluation of bone quantity in open sinus lift technique with space maintaining using platelet rich fibrin (PRF) as sole augmentation material versus nano crystalline hydroxyapatite with simultaneous placing of implants. Read more about this study

Who is it for?
Ages 30 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Atrophied Posterior Maxillary Ridge
What is being tested?
Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite) and Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteEgypt
Study dates
Jul 2015to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All patients should be seeking for implant supported prosthesis in posterior maxilla bilaterally
  • All patients should have atrophied posterior maxillary ridge with the maximum height of the alveolar bone is from 3 mm to 5 mm

Who cannot join

  • Ongoing steroid therapy;
  • Uncontrolled diabetes;
  • Recent cardiovascular diseases;
  • Inflammation of the maxillary sinus;
  • Previous radiant therapy for neoplastic pathologies
  • Patient who have had previous failed sinus augmentation, or exhibited pathological finding or had a history of maxillary sinus disease or operations or whose medical condition might increase surgical risk of the research protocol were excluded.

Trial locations and contacts

1 site in 1 country.

Waleed M. Nour El Din, BDS contact

+2-01001448723

waleed_nour@live.com

Hesham Abdel Hakm, Professor contact

+2-01156096060

surgery@dentistry.cu.edu.eg

Egypt1 site, 1 recruiting
  • Faculty of oral and dental medicine

    Cairo, Cairo Governorate, 11553

    waleed M. Nour El din, BDS, +2-01001448723, waleed_nour@live.com

    Hesham Abdel Hakm, Profeesor, +2-01156096060, surgery@dentistry.cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Evaluation of Bone Quantity in Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite as Sole Grafting Material in Patients With Atrophied Posterior Maxillary Ridge

Evaluation of bone quantity in open sinus lift technique with space maintaining using platelet rich fibrin (PRF) as sole augmentation material versus nano crystalline hydroxyapatite with simultaneous placing of implants.

Read the detailed description

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation using platelet rich fibrin (PRF) versus Nano-crystalline Hydroxyapatite as sole grafting material in patients with atrophied posterior maxillary ridge which provides a new modality for treatment of patients with atrophied posterior maxillary ridge with least cost and a much easier way using platelet rich fibrin (PRF) as substitution to bone graft

Being tested
Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite), Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)
Keywords
simultaneous implantation, Dental implant, Open sinus Lifting, PRF, platelet rich fibrin (PRF)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)Procedure or surgery

    • The sinus cavity will be augmented with bone graft ( Nano crystalline hydroxyapatite)
  • Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)Procedure or surgery

    platelet rich fibrin (PRF) as sole grafting material in created space (PRF)

Study groups in NCT02577289
Study groupRoleWhat they receive
Control group ( Hydroxyappetite)Active comparatorPatients will undergo open sinus lift using nano crystalline hydroxyapatite as augmentation material and placing implants simultaneously then evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)
Receives: Procedure: Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)
Test group (PRF)ExperimentalPatients will undergo open sinus lift using PRF as sole augmentation material and placing implants simultaneously then Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)
Receives: Procedure: Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The amount of new bone formation the sinus cavity using CBCT

    the amount of new bone formation of PRF in comparison with Nano-crystalline hydroxyappetite in millimeters using cone beam computed tomography (CBCT)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2015 (estimated)
  2. Study startJul 2015
  3. Primary completionOct 2017 (estimated)
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02577289
Sponsor's protocol ID
open_sinus_augmentation
Status last verified
Oct 2015
First submitted
13 Oct 2015
Last updated
16 Oct 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Jemt T, Lekholm U. Implant treatment in edentulous maxillae: a 5-year follow-up report on patients with different degrees of jaw resorption. Int J Oral Maxillofac Implants. 1995 May-Jun;10(3):303-11.

    PubMed 7615326
  • Raghoebar GM, Batenburg RH, Timmenga NM, Vissink A, Reintsema H. Morbidity and complications of bone grafting of the floor of the maxillary sinus for the placement of endosseous implants. Mund Kiefer Gesichtschir. 1999 May;3 Suppl 1:S65-9. doi: 10.1007/PL00014520.

    PubMed 10414086
  • Misch CE. Implant design considerations for the posterior regions of the mouth. Implant Dent. 1999;8(4):376-86. doi: 10.1097/00008505-199904000-00008.

    PubMed 10709483
  • Lundgren S, Andersson S, Gualini F, Sennerby L. Bone reformation with sinus membrane elevation: a new surgical technique for maxillary sinus floor augmentation. Clin Implant Dent Relat Res. 2004;6(3):165-73.

    PubMed 15726851
  • Sohn DS, Lee JS, Ahn MR, Shin HI. New bone formation in the maxillary sinus without bone grafts. Implant Dent. 2008 Sep;17(3):321-31. doi: 10.1097/ID.0b013e318182f01b.

    PubMed 18784532
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e51-5. doi: 10.1016/j.tripleo.2005.07.010.

    PubMed 16504851
  • Sakka S, Coulthard P. Bone quality: a reality for the process of osseointegration. Implant Dent. 2009 Dec;18(6):480-5. doi: 10.1097/ID.0b013e3181bb840d.

    PubMed 20009601
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e37-44. doi: 10.1016/j.tripleo.2005.07.008. Epub 2006 Jan 19.

    PubMed 16504849
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e45-50. doi: 10.1016/j.tripleo.2005.07.009. Epub 2006 Jan 10.

    PubMed 16504850
  • Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. doi: 10.1016/j.tripleo.2005.07.011.

    PubMed 16504852
  • Cho JS, Ko YN, Koo HY, Kang YC. Synthesis of nano-sized biphasic calcium phosphate ceramics with spherical shape by flame spray pyrolysis. J Mater Sci Mater Med. 2010 Apr;21(4):1143-9. doi: 10.1007/s10856-009-3980-1. Epub 2010 Jan 6.

    PubMed 20052521
  • Ferraz MP, Monteiro FJ, Manuel CM. Hydroxyapatite nanoparticles: A review of preparation methodologies. J Appl Biomater Biomech. 2004 May-Aug;2(2):74-80.

    PubMed 20803440
  • 20. Best SM, Porter AE, Thian ES, Huang J: Bioceramics: Past, present and for the future. J Eur Ceram Soc 28: 1319, 2008.

  • Bohner M, Baumgart F. Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes. Biomaterials. 2004 Aug;25(17):3569-82. doi: 10.1016/j.biomaterials.2003.10.032.

    PubMed 15020131
  • von Doernberg MC, von Rechenberg B, Bohner M, Grunenfelder S, van Lenthe GH, Muller R, Gasser B, Mathys R, Baroud G, Auer J. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials. 2006 Oct;27(30):5186-98. doi: 10.1016/j.biomaterials.2006.05.051. Epub 2006 Jun 21.

    PubMed 16790273

Questions about this trial

What is this clinical trial studying?

A study testing Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite) and Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF) in people with Atrophied Posterior Maxillary Ridge, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Waleed M. Nour El Din, BDS (+2-01001448723, waleed_nour@live.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The amount of new bone formation the sinus cavity using CBCT (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02577289, which also lists 26 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in